Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Edison Oncology Holding |
Description | Edison Oncology was founded by experienced life-science industry veterans seeking to develop and commercialize new therapies that target |
Keywords | N/A |
WebSite | edisononcology.com |
Host IP | 174.129.30.187 |
Location | United States |
Site | Rank |
US$1,814,789
Last updated: 2023-05-18 19:01:28
edisononcology.com has Semrush global rank of 5,832,250. edisononcology.com has an estimated worth of US$ 1,814,789, based on its estimated Ads revenue. edisononcology.com receives approximately 209,399 unique visitors each day. Its web server is located in United States, with IP address 174.129.30.187. According to SiteAdvisor, edisononcology.com is safe to visit. |
Purchase/Sale Value | US$1,814,789 |
Daily Ads Revenue | US$1,676 |
Monthly Ads Revenue | US$50,256 |
Yearly Ads Revenue | US$603,069 |
Daily Unique Visitors | 13,960 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
edisononcology.com. | A | 3600 | IP: 174.129.30.187 |
edisononcology.com. | A | 3600 | IP: 54.208.101.55 |
edisononcology.com. | NS | 3600 | NS Record: ns24.domaincontrol.com. |
edisononcology.com. | NS | 3600 | NS Record: ns23.domaincontrol.com. |
Edison Oncology Holding Corp Home About Overview Leadership Team Scientific and Clinical Advisors Collaborations and Partnerships Technology Product Pipeline Overview OROTECAN Clinical Trials EO3001 Clinical Trials EO1001 Clinical Trials News & Media Press Releases Presentations & Publications Events In the News Contact Careers Targeting Major Cancer Markets Edison Oncology was founded in 2018 by experienced life science industry veterans to develop and commercialize new therapies targeting the fight against cancer. About Edison Oncology Identifying and Advancing Underdeveloped Candidates By leveraging our deep understanding of tumor biology and translational drug development expertise, we seek to identify and acquire select underdeveloped drug candidates, and specifically target them to patients whose tumors are most likely to respond to therapy. View Our Approach Developing Disruptive Drug Candidates We are developing a pipeline of unique small-molecule product candidates, each with |
HTTP/1.1 301 Moved Permanently Date: Fri, 15 Jul 2022 08:50:26 GMT Server: Apache Location: https://www.edisononcology.com/ Content-Type: text/html; charset=UTF-8 HTTP/1.1 200 OK Date: Fri, 15 Jul 2022 08:50:27 GMT Server: Apache Expires: Thu, 19 Nov 1981 08:52:00 GMT Cache-Control: no-store, no-cache, must-revalidate, post-check=0, pre-check=0 Pragma: no-cache Set-Cookie: major_announcement=deleted; expires=Thu, 01-Jan-1970 00:00:01 GMT; Max-Age=0 Content-Type: text/html; charset=UTF-8 |
Domain Name: EDISONONCOLOGY.COM Registry Domain ID: 2221306485_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2018-01-31T17:28:57Z Creation Date: 2018-01-31T17:28:57Z Registry Expiry Date: 2023-01-31T17:28:57Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS23.DOMAINCONTROL.COM Name Server: NS24.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-07-15T08:54:42Z <<< |